Urotrials Company (gmbh)

This study is a long-term registry that will follow 5000 men with prostate cancer that has come back or spread. It includes four groups: men with a rising PSA after initial treatment, those whose cancer resists hormone therapy but hasn't spread, those with newly spread cancer, an…